Order Article Reprints

Pavese F, Capoluongo ED, Muratore M, Minucci A, Santonocito C, Fuso P, Concolino P, Di Stasio E, Carbognin L, Tiberi G, et al. BRCA Mutation Status in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: A Pivotal Role for Treatment Decision-Making. Cancers. 2022; 14(19):4571. https://doi.org/10.3390/cancers14194571

Pavese, Francesco, Ettore Domenico Capoluongo, Margherita Muratore, Angelo Minucci, Concetta Santonocito, Paola Fuso, Paola Concolino, Enrico Di Stasio, Luisa Carbognin, Giordana Tiberi, and et al. 2022. "BRCA Mutation Status in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: A Pivotal Role for Treatment Decision-Making" Cancers 14, no. 19: 4571. https://doi.org/10.3390/cancers14194571

Pavese, F., Capoluongo, E. D., Muratore, M., Minucci, A., Santonocito, C., Fuso, P., Concolino, P., Di Stasio, E., Carbognin, L., Tiberi, G., Garganese, G., Corrado, G., Di Leone, A., Generali, D., Fragomeni, S. M., D’Angelo, T., Franceschini, G., Masetti, R., Fabi, A., ... Paris, I. (2022). BRCA Mutation Status in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: A Pivotal Role for Treatment Decision-Making. Cancers, 14(19), 4571. https://doi.org/10.3390/cancers14194571